These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29335408)

  • 41. Induction of the IL-1RII decoy receptor by NFAT/FOXP3 blocks IL-1β-dependent response of Th17 cells.
    Kim DH; Kim HY; Cho S; Yoo SJ; Kim WJ; Yeon HR; Choi K; Choi JM; Kang SW; Lee WW
    Elife; 2021 Jan; 10():. PubMed ID: 33507149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Feasibility of real-time in vivo 89Zr-DFO-labeled CAR T-cell trafficking using PET imaging.
    Lee SH; Soh H; Chung JH; Cho EH; Lee SJ; Ju JM; Sheen JH; Kim H; Oh SJ; Lee SJ; Chung J; Choi K; Kim SY; Ryu JS
    PLoS One; 2020; 15(1):e0223814. PubMed ID: 31910217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trained and ready - the case for an inflammatory memory for hematopoietic stem and progenitor cells in the AML niche.
    Chen DW; Wafula EK; Kurre P
    Oncotarget; 2024 Sep; 15():609-613. PubMed ID: 39236060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche.
    Chen DW; Fan JM; Schrey JM; Mitchell DV; Jung SK; Hurwitz SN; Perez EB; Muraro MJ; Carroll M; Taylor DM; Kurre P
    Leukemia; 2024 Apr; 38(4):741-750. PubMed ID: 38228679
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The potential role of the thymus in immunotherapies for acute myeloid leukemia.
    Hino C; Xu Y; Xiao J; Baylink DJ; Reeves ME; Cao H
    Front Immunol; 2023; 14():1102517. PubMed ID: 36814919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of double-positive thymocytes at single-cell resolution.
    Li Y; Li K; Zhu L; Li B; Zong D; Cai P; Jiang C; Du P; Lin J; Qu K
    Genome Med; 2021 Mar; 13(1):49. PubMed ID: 33771202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T cell optimization for graft-versus-leukemia responses.
    Biernacki MA; Sheth VS; Bleakley M
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escape from thymic deletion and anti-leukemic effects of T cells specific for hematopoietic cell-restricted antigen.
    Ju JM; Jung MH; Nam G; Kim W; Oh S; Kim HD; Kim JY; Chang J; Lee SH; Park GS; Min CK; Lee DS; Kim MG; Choi K; Choi EY
    Nat Commun; 2018 Jan; 9(1):225. PubMed ID: 29335408
    [TBL] [Abstract][Full Text] [Related]  

  • 49. H60: A Unique Murine Hematopoietic Cell-Restricted Minor Histocompatibility Antigen for Graft-versus-Leukemia Effect.
    Choi EY; Choi K; Nam G; Kim W; Chung M
    Front Immunol; 2020; 11():1163. PubMed ID: 32587590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Subdominant H60 antigen-specific CD8 T-cell response precedes dominant H4 antigen-specific response during the initial phase of allogenic skin graft rejection.
    Yoo KI; Jeon JY; Ryu SJ; Nam G; Youn H; Choi EY
    Exp Mol Med; 2015 Feb; 47(2):e140. PubMed ID: 25676063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
    Bosco N; Swee LK; Bénard A; Ceredig R; Rolink A
    Exp Hematol; 2010 Mar; 38(3):222-232.e2. PubMed ID: 20045443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
    Lucca LE; Axisa PP; Aloulou M; Perals C; Ramadan A; Rufas P; Kyewski B; Derbinski J; Fazilleau N; Mars LT; Liblau RS
    Eur J Immunol; 2016 Sep; 46(9):2247-59. PubMed ID: 27334749
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tolerance is established in polyclonal CD4(+) T cells by distinct mechanisms, according to self-peptide expression patterns.
    Malhotra D; Linehan JL; Dileepan T; Lee YJ; Purtha WE; Lu JV; Nelson RW; Fife BT; Orr HT; Anderson MS; Hogquist KA; Jenkins MK
    Nat Immunol; 2016 Feb; 17(2):187-95. PubMed ID: 26726812
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.